carmustine has been researched along with Thoracic Neoplasms in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, O | 1 |
| Benhamou, E | 1 |
| Beaujean, F | 1 |
| Kalifa, C | 1 |
| Lejars, O | 1 |
| Patte, C | 1 |
| Behard, C | 1 |
| Flamant, F | 1 |
| Thyss, A | 1 |
| Deville, A | 1 |
1 other study available for carmustine and Thoracic Neoplasms
| Article | Year |
|---|---|
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Disease | 1987 |